Durable responses to avelumab (anti-PD-L1) in patients with Merkel cell carcinoma progressed after chemotherapy: 1-year efficacy update - Kaufmann, H; Russel, J; Hamid, O
Oral presentation at: American Association for Cancer Research Annual Meeting; June 2017; Chicago, IL